The present work describes the dual behavior of two inhibitors of the PI3K/AKT pathway, namely quercetin and STL1, in modulating autophagy and apoptosis in a CLL-derived cell line. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.